Results from 2 studies suggest that adding ICIs to treatment can improve outcomes for patients with resectable HNSCC.

Amid the growing popularity of cannabis, it is perhaps not surprising that clinicians are increasingly accepting its use among cancer survivors,” the researchers wrote.

Soon, many patients might initiate contact with the health system not by speaking with a call center worker or receptionist, but with AI.

COVID-19 cases are on the rise again across the United States, according to data from the US Centers for Disease Control and Prevention.

The US Food and Drug Administration (FDA) has granted priority review to TAR-200 for the treatment of patients with Bacillus Calmette-Guérin (BCG)-unresponsive, high-risk non-muscle invasive bladder ...

Thousands of workers at federal health agencies lost their jobs this week after a US Supreme Court ruling cleared the way for the Trump administration to move forward with major staffing cuts.

The findings of this case series study show substantial variation in the choice of the TNT regimen and were overall aligned with those reported in clinical trials, suggesting the efficacy of TNT in a ...

US patients with metastatic urothelial cancer have seen improvements in survival since ICIs and ADCs have entered the market, data suggest.

Adding ICIs to chemotherapy ± antiangiogenic therapy improves survival outcomes in advanced NSCLC that is resistant to EGFR-TKIs.

Adjuvant chemoradiation combined with camrelizumab was well tolerated and yielded significantly improved long-term survival,” the researchers wrote.

Even before recent layoffs, the FDA’s investigative force struggled to monitor drug-making factories in India and China.

Breastfeeding did not appear to be associated with a higher risk of developing locoregional recurrences or contralateral breast cancers,” researchers wrote.